The US National Kidney Foundation did not recommend routine administration of L-carnitine to subjects undergoing dialysis yet encouraged the development of trials in patients with select symptoms that do not respond to standard therapy, i.e., persistent muscle cramps or hypotension during dialysis, severe fatigue, skeletal muscle weakness or myopathy, cardiomyopathy, and anemia requiring large doses of erythropoietin (74, 75)
Whether you're managing high stress, anxiety, or simply seeking a restorative reset, this treatment invites your body back into a state of calm clarity
People considering peptide therapy should work with licensed medical providers or regulated pharmacies where applicable
C.Lacas-GervaisS.FragakiK.et al
doi: 10.1097/00075198-200102000-00001 21 MoraesTJDowneyGP